Safety and efficacy of linagliptin as add-on therapy to metformin in patients with type 2 diabetes: a randomized, double-blind, placebo-controlled study.

Saved in:
Bibliographic Details
Title: Safety and efficacy of linagliptin as add-on therapy to metformin in patients with type 2 diabetes: a randomized, double-blind, placebo-controlled study.
Authors: Taskinen, M.-R.1 marja-riitta.taskinen@helsinki.fi, Rosenstock, J.2, Tamminen, I.3, Kubiak, R.4, Patel, S.5, Dugi, K. A.6,7, Woerle, H.-J.5
Source: Diabetes, Obesity & Metabolism. Jan2011, Vol. 13 Issue 1, p65-74. 10p. 1 Diagram, 3 Charts, 5 Graphs.
Database: Academic Search Ultimate
Description
ISSN:14628902
DOI:10.1111/j.1463-1326.2010.01326.x